Temple Syndrome in a Patient With Variably Methylated CpGs at the Primary MEG3/DLK1:IG-DMR and Severely Hypomethylated CpGs at the Secondary MEG3:TSS-DMR

Clinical Epigenetics - Germany
doi 10.1186/s13148-019-0640-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The IG-DMR and the MEG3-DMR at Human Chromosome 14q32.2: Hierarchical Interaction and Distinct Functional Properties as Imprinting Control Centers

PLoS Genetics
EvolutionEcologyGeneticsMolecular BiologyCancer ResearchSystematicsBehavior
2010English

S25– Ethical Aspects in CPGs

Otolaryngology - Head and Neck Surgery
OtorhinolaryngologySurgery
2010English

Hypermethylation of MEG3 Promoter Correlates With Inactivation of MEG3 and Poor Prognosis in Patients With Retinoblastoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors

PLoS ONE
Multidisciplinary
2013English

The Imprinted DLK1-MEG3 Gene Region on Chromosome 14q32.2 Alters Susceptibility to Type 1 Diabetes

Nature Genetics
Genetics
2009English

Reduced DNA Methylation at the PEG3 DMR and KvDMR1 Loci in Children Exposed to Alcohol in Utero: A South African Fetal Alcohol Syndrome Cohort Study

Frontiers in Genetics
GeneticsMolecular Medicine
2015English

Table 1: Parameters for Diabetic Rats Treated With pcDNA3-MEG3 at Week 12.

English

Supplemental Information 2: DMR

English

Loss of CpG Methylation Is Strongly Correlated With Loss of Histone H3 Lysine 9 Methylation at DMR-LIT1 in Patients With Beckwith-Wiedemann Syndrome

American Journal of Human Genetics
Genetics
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy